12 results
Summary of dosing recommendations in renal impairment of commonly used hypoglycaemic agents

#Diabetes #Diabetic #Medications #Pharmacology #Dosing
hypoglycaemic agents ... #Diabetes #Diabetic ... #Medications #Pharmacology ... Renal #Impairment #CKD ... #Table #GFR #Hypoglycemics
Pain Assessment and Management Initiative (PAMI) - Neuropathic Pain Medications:

Agent, Initiation Dose and Max Dosages

 -
: Agent, Initiation ... Dose and Max Dosages ... Management #Pain #Pharmacology ... #Doses #Dosing ... #Table #PAMI
Oral anti-hypertensives with relative fast onset of action (Hypertensive Emergency)

The key concern with oral antihypertensive agents
important to allow one dose ... you escalate the dose ... doses, which allows ... Emergency #Management #Pharmacology ... #Table #BloodPressure
Pain Assessment and Management Initiative (PAMI) - Non-Opioid Analgesics - Agents and Dosing

#Management #Pain #Pharmacology #NonOpioid
Non-Opioid Analgesics - Agents ... #Pain #Pharmacology ... NonOpioid #Analgesics #Medications ... #Doses #Dosing ... #Table #PAMI
Pain Assessment and Management Initiative (PAMI) - Muscle Relaxants - Agents and Dosing

#Management #Pain #Pharmacology #Muscle
Muscle Relaxants - Agents ... #Pain #Pharmacology ... Relaxers #Relaxants #Medications ... #Doses #Dosing ... #Table #PAMI
Phosphate binders - quick reference chart of maximum daily dose. Most patients with CKD will require
maximum daily dose ... Generally, the initial dose ... phosphate levels and doses ... Hyperphosphatemia #Dose ... #Dosing #Pharmacology
Pain Assessment and Management Initiative (PAMI) - Nerve Blocks - Nerve Distribution, Agents and Dosing Table
Distribution, Agents ... and Dosing Table ... Management #Pain #Pharmacology ... Nerve #Blocks #Medications ... #Doses #Dosing
Pain Assessment and Management Initiative (PAMI) - Intranasal and Nebulized Medications- Agents and Dosing

#Management #Pain #Pharmacology
and Nebulized Medications ... - Agents and Dosing ... Management #Pain #Pharmacology ... #Doses #Dosing ... #Table #PAMI
Rybelsus (oral semaglutide) - First Oral GLP-1 Agonist
Dosing:
3 mg daily x 30 days, then 7 mg
-1 Agonist Dosing ... mg maintenance dose ... smaller starting dose ... the maintenance dose ... the maintenance dose
Potassium-Binding Agents to Treat Hyperkalemia
Sodium zirconium cyclosilicate (Lokelma):
 • Mechanism: Preferentially captures K in exchange for
Potassium-Binding Agents ... 10 g QD (adjust dose ... Usual maintenance dose ... g QD; increase dose ... #pharmacology #